14 February 1992
COMMERCIAL ITEM DESCRIPTION
CEPHRADINE CAPSULES, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-C-37441A which is cancelled.
Shall be Cephradine Capsules, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
For Strength I, shall contain 250 mg of Cephradine per capsule, within the applicable assay limits.
For Strength II, shall contain 500 mg of Cephradine per capsule, within the applicable assay limits.
Each capsule shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The capsules shall be free from defects which detract from their appearance or impair their serviceability.
For Size 1, one bottle containing 100 capsules, as specified, constitutes one unit.
For Size 2, shall be supplied 100 capsules, individually sealed in commercially available blister or strip packaging. One package containing 100 individually sealed capsules, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business